We are live on ! Find out more
KA

Kintegral Advisory Portfolio holdings

AUM $1.06B
1-Year Est. Return 24.93%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$550M
AUM Growth
+$47.8M
Cap. Flow
-$677K
Cap. Flow %
-0.12%
Top 10 Hldgs %
28.86%
Holding
269
New
1
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$991K
2
TFC icon
Truist Financial
TFC
+$326K
3
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$45K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.72M
2
STI
SunTrust Banks, Inc.
STI
+$320K
3
MMM icon
3M
MMM
+$560

Sector Composition

Rank Sector Weight
1 Technology 27.68%
2 Healthcare 14.72%
3 Financials 13.9%
4 Communication Services 10.73%
5 Consumer Staples 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGO icon
101
Broadcom
AVGO
$1.87T
$1.42M 0.26%
44,830
– –
SCHW
102
Charles Schwab
SCHW
$177B
$1.41M 0.26%
29,576
– –
TFC icon
103
Truist Financial
TFC
$62.5B
$1.41M 0.26%
24,961
+6,018
+32% +$326K
HLT icon
104
Hilton Worldwide
HLT
$72.9B
$1.4M 0.25%
12,620
– –
PBCT
105
DELISTED
People's United Financial Inc
PBCT
$1.39M 0.25%
82,366
– –
VFC icon
106
VF Corp
VFC
$6.49B
$1.39M 0.25%
13,904
– –
TRV icon
107
Travelers Companies
TRV
$78.5B
$1.38M 0.25%
10,041
– –
CMA
108
DELISTED
Comerica
CMA
$1.37M 0.25%
18,857
– –
PYPL icon
109
PayPal
PYPL
$49.4B
$1.34M 0.24%
12,390
– –
DE icon
110
Deere & Co
DE
$165B
$1.33M 0.24%
7,642
– –
QCOM icon
111
Qualcomm
QCOM
$180B
$1.33M 0.24%
15,026
– –
ICE icon
112
Intercontinental Exchange
ICE
$81B
$1.31M 0.24%
14,183
– –
APD icon
113
Air Products & Chemicals
APD
$65.5B
$1.3M 0.24%
5,510
– –
IFF icon
114
International Flavors & Fragrances
IFF
$18.8B
$1.29M 0.23%
9,924
– –
LLY icon
115
Eli Lilly
LLY
$1.06T
$1.27M 0.23%
9,667
– –
HUM icon
116
Humana
HUM
$47.4B
$1.23M 0.22%
3,353
– –
TEL icon
117
TE Connectivity
TEL
$58B
$1.21M 0.22%
12,664
– –
SHW icon
118
Sherwin-Williams
SHW
$76.6B
$1.21M 0.22%
6,219
– –
DGX icon
119
Quest Diagnostics
DGX
$25.2B
$1.19M 0.22%
11,177
– –
ED icon
120
Consolidated Edison
ED
$41.6B
$1.18M 0.22%
13,085
– –
XYL icon
121
Xylem
XYL
$27.8B
$1.18M 0.21%
14,957
– –
CPB icon
122
Campbell Soup
CPB
$6.38B
$1.16M 0.21%
23,424
– –
SPG icon
123
Simon Property Group
SPG
$73B
$1.16M 0.21%
7,770
– –
MSI icon
124
Motorola Solutions
MSI
$67.6B
$1.15M 0.21%
7,076
– –
LRCX icon
125
Lam Research
LRCX
$400B
$1.14M 0.21%
38,970
– –
3 4
5
6 7

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return

Kintegral Advisory's Q4 2019 Portfolio in Review

As of Q4 2019, Kintegral Advisory held 269 positions worth $550M, up 9.5% from $502M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 1.1%. Kintegral Advisory opened 1 new position and exited 2, leaving the 269-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Kintegral Advisory's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 17,299 shares worth $52K.
  • Kintegral Advisory added most to Bristol-Myers Squibb in Q4 2019, an estimated $991K increase.
  • Kintegral Advisory's biggest Q4 2019 reduction was 3M, cutting an estimated $560.
  • Kintegral Advisory fully exited Celgene Corp in Q4 2019, selling an estimated $1.72M.
  • Kintegral Advisory's ten largest holdings make up 29% of its $550M portfolio in Q4 2019.
  • Kintegral Advisory opened 1 new position and closed 2 in Q4 2019.
  • Kintegral Advisory's portfolio value rose 9.5% quarter-over-quarter to $550M.

Based on Kintegral Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.